TR
EN
Patent File Information
Application Information
Applicants
| Person No | Name | Address |
|---|---|---|
| 8003294 | ELI LILLY AND COMPANY | LILLY CORPORATE CENTER INDIANAPOLIS, IN 46285 A.B.D. |
Inventors
| Person No | Name | Address |
|---|---|---|
| 8003289 | James Benedict CANAVAN | INDIANAPOLIS, 46206-6288 A.B.D. |
| 8003290 | Stuart William FRIEDRICH | INDIANAPOLIS, 46206-6288 A.B.D. |
| 8003293 | Jay Lawrence TUTTLE | INDIANAPOLIS, 46206-6288 A.B.D. |
| 8003292 | Catherine MILCH | INDIANAPOLIS, 46206-6288 A.B.D. |
| 8003291 | Kathryn Ann KRUEGER | INDIANAPOLIS, 46206-6288 A.B.D. |
Invention Information
| Name Of Invention | Ülseratif kolit tedavisinde mirikizumab | |
| Summary Of Invention | Konu olan buluş genel olarak ülseratif kolitin bir anti-IL-23p19 antikoru ile tedavisi, özellikle hastalığın tedavisine yönelik dozaj rejimleri ile ilgilidir. | |
Attorney Information
| Name |
CEREN AYYÜREK
STOCK FİKRİ MÜLKİYET HİZMETLERİ ANONİM ŞİRKETİ |
| Address | ***** İSTANBUL |
Priority Information
| Date of Priority | Priority Number | Country of Priority |
|---|---|---|
| 30-03-2018 | US 201862650314P | US |
Classes of The Invention
| IPC |
|---|
| A61K39/395 |
| A61P1/04 |
| C07K16/24 |
Patent Application Procedures
| Date | Date of Notification | Operation | Document |
|---|---|---|---|
| 18-03-2026 | Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı. |
|
|
| 23-02-2026 | EPO'dan Gelen Patent Fasikül |
|
|
| 27-02-2026 | Yıllık Ücret Ödeme Talebi |
|
Publications
| Publication Date | Description |
|---|---|
| 23-03-2026 | Avrupa Patent Fasiküllerinin İlanı |
Payment Dates
| Row | Year | Payment Date | Amount Paid (₺) |
|---|---|---|---|
| 8 | 2026 | 27-02-2026 | 8530.0 |